Can Commun Dis Rep. 2017 Nov 2;43(11):217-219. doi: 10.14745/ccdr.v43i11a01.
Antimicrobial-resistant infections are becoming more frequent and increasingly difficult to treat, and this situation is exacerbated by the widespread use of antimicrobials in both human and veterinary medicine and by the agriculture industry. As part of Canada's coordinated response to addressing antimicrobial resistance (AMR), was released in September 2017. The Framework is a high-level policy document that outlines the strategic objectives, outcomes and opportunities to guide collaborative action on AMR and antimicrobial use (AMU). It is grounded in a One Health approach, and was developed in collaboration with federal, provincial and territorial governments and external stakeholders in the human and animal health sectors. The Framework is based on four components: surveillance; infection prevention and control; stewardship; and research and innovation. It builds upon existing AMR activities already underway in the human and animal health sectors and strives to connect these activities together to strengthen Canada's approach to AMR.
抗微生物药物耐药性感染正变得越来越频繁且愈发难以治疗，而人类医学、兽医学以及农业领域广泛使用抗微生物药物使这种情况更加恶化。作为加拿大应对抗微生物药物耐药性（AMR）的协调行动的一部分，该框架于2017年9月发布。该框架是一份高层政策文件，概述了指导AMR和抗微生物药物使用（AMU）方面合作行动的战略目标、成果和机遇。它基于“同一健康”方法，并与联邦、省和地区政府以及人类和动物卫生领域的外部利益相关者合作制定。该框架基于四个组成部分：监测；感染预防与控制；管理；以及研究与创新。它以人类和动物卫生领域已经开展的现有AMR活动为基础，并努力将这些活动联系起来，以加强加拿大应对AMR的方法。
